GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sinew Pharma Inc (ROCO:6634) » Definitions » Median PS Value

Sinew Pharma (ROCO:6634) Median PS Value : NT$0.00 (As of May. 17, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Sinew Pharma Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Sinew Pharma's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was NT$0. Sinew Pharma's 10-Year median PS Ratio is . Therefore, the Median PS Value for today is NT$0.00.

As of today (2024-05-17), Sinew Pharma's share price is NT$56.30. Sinew Pharma's Median PS Value is NT$0.00. Therefore, Sinew Pharma's Price to Median PS Value for today is 0.00.

The historical rank and industry rank for Sinew Pharma's Median PS Value or its related term are showing as below:

ROCO:6634's Price-to-Median-PS-Value is not ranked *
in the Biotechnology industry.
Industry Median: 0.71
* Ranked among companies with meaningful Price-to-Median-PS-Value only.

Sinew Pharma Median PS Value Historical Data

The historical data trend for Sinew Pharma's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinew Pharma Median PS Value Chart

Sinew Pharma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Median PS Value
Get a 7-Day Free Trial Premium Member Only - - - - -

Sinew Pharma Semi-Annual Data
Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Sinew Pharma's Median PS Value

For the Biotechnology subindustry, Sinew Pharma's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sinew Pharma's Price-to-Median-PS-Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sinew Pharma's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Sinew Pharma's Price-to-Median-PS-Value falls into.



Sinew Pharma Median PS Value Calculation

Sinew Pharma's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=0*
=0.00

10-Year Median PS Ratio is .
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sinew Pharma's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was NT$0.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sinew Pharma  (ROCO:6634) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Sinew Pharma's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=56.30/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sinew Pharma Median PS Value Related Terms

Thank you for viewing the detailed overview of Sinew Pharma's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinew Pharma (ROCO:6634) Business Description

Traded in Other Exchanges
N/A
Address
C516, Building C, Number 99, Lane 130, Section 1, Yuanyuan Road, Nangang District, Taipei, TWN, 11571
Sinew Pharma Inc is a Taiwan based biopharmaceutical company. It focuses on integrated new drug research and development. The company produces liver disease treatment medicines, pain treatment drugs, animal medicines, and other products. Its product portfolio includes SNP-610, SNP-630, SNP-810, SNP-820, SNP-830 and SNP-840.

Sinew Pharma (ROCO:6634) Headlines

No Headlines